Weight loss drugsCardiovascular diseaseOverweight and obesity have been rising dramatically worldwide and are an independent risk factor for cardiovascular disease (CVD). The majority of overweight and obese patients who achieve a significant short-term weight loss fail to maintain their lower weight in...
Weight-loss drugs are poised to revolutionise healthcare by slowing down the ageing process and by allowing people to live for longer and in better health. That is the dramatic message from leading …
“These studies reinforce the potential of GLP-1-based therapies not only to aid in weight loss but also to transform cardiac health, offering hope for patients living with obesity andcardiovascular disease,” said Harlan M. Krumholz, MD, SM, editor-in-chief ofJACCand the Harold H. Hines Jr...
The latest prescription drugs, like Zepbound, Wegovy and Saxenda are approved for chronic (long-term) weight loss and come as subcutaneous (under the skin) injections.Up to a 20% weight loss, or higher, has been seen with these newer treatments, but some people need to stop treatment ...
Follow the latest Weight-loss drugs news stories and headlines. Get breaking news alerts when you download the ABC News App and subscribe to Weight-loss drugs notifications.
WEIGHT-LOSS DRUGS COULD REDUCE COVID-RELATED DEATHS: STUDY Dr. Pat Basu, managing partner at Varsity Healthcare Partners, told FOX Business that it is probable that several children are going to benefit from this. "It's important to remember, really, that the childhood obesit...
For decades, weight-loss drugs have been a disappointment, delivering ineffective or even dangerous treatments. The recent arrival of drugs that are both effective and safe is therefore a medical mi…
Obesity dipped slightly in U.S. adults last year, research found — the first time in more than a decade that the country has seen a downward trend. That might be due, in part, to the recent rise of blockbuster weight loss drugs like Ozempic, accordin... ...
Some experts warn that weight-loss drugs are not a panacea. Some Wegovy users have expressed concerns about side effects and the risk of regaining weight after stopping the treatment. Instead of "miracle" drugs, the majority of those overweight might need medications with a milder, more gradual...
“The weight loss attributes of the drugs are responsible for most of the benefits in multiple diseases, or are the predominant reason why these drugs affect multiple diseases,” he says. As new and stronger drugs emerge, these effects are likely to increase. Novo Nordisk’s chief executive La...